 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - PRASAD SUYASH
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-09-01 Sale | 2017-09-01 5:55 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 8,000 | $21.44 | $171,481 | 0 (Direct) | View |
| 2017-12-01 Sale | 2017-12-05 4:00 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 8,000 | $28.53 | $228,264 | 0 (Direct) | View |
| 2018-03-26 Sale | 2018-03-28 9:12 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 2,200 | $30 | $66,000 | 0 (Direct) | View |
| 2018-03-29 Sale | 2018-03-29 8:23 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 7,800 | $30.02 | $234,195 | 0 (Direct) | View |
| 2018-07-02 Sale | 2018-07-05 6:35 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 4,989 | $38.02 | $189,704 | 0 (Direct) | View |
| 2018-10-01 Sale | 2018-10-02 7:05 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $36.88 | $368,788 | 0 (Direct) | View |
| 2019-02-25 Sale | 2019-02-27 4:32 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $30.06 | $300,553 | 18,236 (Direct) | View |
| 2019-05-13 Sale | 2019-05-15 4:42 pm | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $36.98 | $369,798 | 18,236 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-01-25 Option Award | 2017-01-27 6:10 pm | N/A 2027-01-25 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 70,000 | $15.26 | 70,000 (Direct) | View |
| 2017-09-01 Exercise | 2017-09-01 5:55 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 8,000 | $0.79 | 0 (Direct) | View |
| 2017-09-01 Exercise | 2017-09-01 5:55 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 8,000 | $0.79 | 0 (Direct) | View |
| 2017-11-16 Option Award | 2017-11-17 5:07 pm | N/A 2027-11-16 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 75,000 | $27.39 | 75,000 (Direct) | View |
| 2017-12-01 Exercise | 2017-12-05 4:00 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 6,770 | $0.79 | 0 (Direct) | View |
| 2017-12-01 Exercise | 2017-12-05 4:00 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 1,230 | $0.79 | 0 (Direct) | View |
| 2017-12-01 Exercise | 2017-12-05 4:00 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 8,000 | $0.79 | 0 (Direct) | View |
| 2018-03-26 Exercise | 2018-03-28 9:12 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 1,900 | $0.79 | 0 (Direct) | View |
| 2018-03-26 Exercise | 2018-03-28 9:12 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 300 | $0.79 | 0 (Direct) | View |
| 2018-03-26 Exercise | 2018-03-28 9:12 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 1,900 | $0.79 | 0 (Direct) | View |
| 2018-03-26 Exercise | 2018-03-28 9:12 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 300 | $0.79 | 0 (Direct) | View |
| 2018-03-29 Exercise | 2018-03-29 8:23 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 7,800 | $0.79 | 0 (Direct) | View |
| 2018-03-29 Exercise | 2018-03-29 8:23 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 7,800 | $0.79 | 0 (Direct) | View |
| 2018-07-02 Exercise | 2018-07-05 6:35 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 4,989 | $0.79 | 0 (Direct) | View |
| 2018-07-02 Exercise | 2018-07-05 6:35 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 5,011 | $0.79 | 0 (Direct) | View |
| 2018-07-02 Sale | 2018-07-05 6:35 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 5,011 | $38.79 | 0 (Direct) | View |
| 2018-07-02 Exercise | 2018-07-05 6:35 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 4,989 | $0.79 | 0 (Direct) | View |
| 2018-07-02 Exercise | 2018-07-05 6:35 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 5,011 | $0.79 | 0 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 100 | $0.79 | 0 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 1,101 | $0.79 | 0 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 3,900 | $0.79 | 0 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 200 | $0.79 | 0 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 4,699 | $0.79 | 0 (Direct) | View |
| 2018-10-01 Exercise | 2018-10-02 7:05 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 0 (Direct) | View |
| 2018-11-15 Option Award | 2018-11-16 6:37 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 736 | $19.64 | 736 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:25 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 17,500 | $0 | 48,750 (Direct) | View |
| 2019-02-06 Option Award | 2019-02-08 5:25 pm | N/A 2029-02-06 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 48,750 | $24.74 | 48,750 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 18,236 (Direct) | View |
| 2019-02-25 Exercise | 2019-02-27 4:32 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 18,236 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:42 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 18,236 (Direct) | View |
| 2019-05-13 Exercise | 2019-05-15 4:42 pm | N/A 2024-02-18 | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 10,000 | $0.79 | 18,236 (Direct) | View |
| 2019-06-05 Tax Withholding | 2019-06-07 4:42 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | PRASAD SUYASH Senior VP & Chief Med Officer | 757 | $37.31 | 17,479 (Direct) | View |
| 2020-09-23 Option Award | 2020-09-25 5:14 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 668,745 | $0 | 668,745 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:39 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 3,844 | $0 | 0 (Direct) | View |
| 2020-09-28 Conversion | 2020-09-30 4:39 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 3,529 | $0 | 0 (Direct) | View |
| 2021-01-19 Option Award | 2021-01-20 8:21 pm | N/A 2031-01-19 | Taysha Gene Therapies Inc. | TSHA | PRASAD SUYASH CMO and Head of R&D | 80,000 | $31 | 80,000 (Direct) | View |